Literature DB >> 16835380

Presence of neutrophil-bearing antigen in lymphoid organs of immune mice.

Belkys A Maletto1, Andrea S Ropolo, Diego O Alignani, Miriam V Liscovsky, Romina P Ranocchia, Victor Gabriel Moron, María C Pistoresi-Palencia.   

Abstract

Neutrophils play a crucial early role during the innate response, but little is known about their possible contribution when an adaptive immune response is installed. A robust neutrophilia and a T helper 1 (Th1) immune response are present after immunization with Complete Freund Adjuvant (CFA). We show that when FITC-labeled OVA was injected into the footpad of OVA/CFA immunized mice, the main OVA-FITC+ cells recruited in draining popliteal lymph nodes (LNs) were neutrophils, with most of them arriving at the LN by means of lymphatic vessels. The development of this OVA-FITC+ neutrophil influx requires an immune response against OVA. The OVA-FITC+ neutrophils present in LNs displayed mainly intracellular TNF-alpha, and their depletion resulted in an increase in the specific IL-5 levels. These data provide new evidence about the role played by neutrophils in vivo in adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835380     DOI: 10.1182/blood-2006-04-016659

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

Review 1.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients.

Authors:  Suyang Hao; Mary Andersen; Hongbo Yu
Journal:  Am J Blood Res       Date:  2013-08-19

3.  IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation.

Authors:  Craig M Brackett; Jason B Muhitch; Sharon S Evans; Sandra O Gollnick
Journal:  J Immunol       Date:  2013-09-11       Impact factor: 5.422

4.  HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.

Authors:  Jun Fu; Beverly E Sha; Larry L Thomas
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

5.  Neutrophils clear bacteria associated with parasitic nematodes augmenting the development of an effective Th2-type response.

Authors:  John T Pesce; Zhugong Liu; Hossein Hamed; Farhang Alem; Jeanette Whitmire; Hongxia Lin; Qian Liu; Joseph F Urban; William C Gause
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  Inflammation and wound repair.

Authors:  Danny C LeBert; Anna Huttenlocher
Journal:  Semin Immunol       Date:  2014-05-19       Impact factor: 11.130

7.  Spatiotemporal photolabeling of neutrophil trafficking during inflammation in live zebrafish.

Authors:  Sa Kan Yoo; Anna Huttenlocher
Journal:  J Leukoc Biol       Date:  2011-01-19       Impact factor: 4.962

8.  Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation.

Authors:  Nassrine Bachsais; Lila Boussag-Abib; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2017-05-17       Impact factor: 4.575

9.  The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation.

Authors:  Danielle Minns; Katie J Smith; Virginia Alessandrini; Gareth Hardisty; Lauren Melrose; Lucy Jackson-Jones; Andrew S MacDonald; Donald J Davidson; Emily Gwyer Findlay
Journal:  Nat Commun       Date:  2021-02-24       Impact factor: 14.919

10.  Pivotal Advance: Pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish.

Authors:  Catherine A Loynes; Jane S Martin; Anne Robertson; Daniel M I Trushell; Philip W Ingham; Moira K B Whyte; Stephen A Renshaw
Journal:  J Leukoc Biol       Date:  2010-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.